The signatories want Congress to mandate screening for synthetic DNA sales as AI makes creating a bioweapon easier.

Leading AI labs, executives, and scientists are sending a letter to lawmakers urging them to improve tracking of synthetic DNA sequences that could be used for bioweapons.

OpenAI CEO Sam Altman will advocate against proposals that AI developers obtain U.S. government approval before releasing new models to the public, according to a company…